Ann Intern Med

1. MELILLO G
   Team up to vaccinate.
   Ann Intern Med. 2026 Jun 9. doi: 10.7326/ANNALS-26-02411.
   

   >> Share

   
   

   
   BMJ

2. TANNE JH
   Vaccination: RFK Jr cited autism link studies are retracted as Trump doubles down on recommendation changes.
   BMJ. 2026;393:e595295.
   

   >> Share

   
   

   
   Clin Infect Dis

3. ROUPHAEL N
   Zoster Vaccination and Dementia: Interpreting the Signal and Testing the Mechanisms.
   Clin Infect Dis. 2026 Jun 8:ciag358. doi: 10.1093.
   

   >> Share

   
   

   
   Infect Immun

4. MILLER JM, Ozyck RG, Mara AB, Hernandez EF, et al
   Recombinant subunit vaccine against Mycoplasma gallisepticum disease confers cross-protection against multiple pathogenic strains.
   Infect Immun. 2026 Jun 12:e0002526. doi: 10.1128/iai.00025.
   

   >> Share

   
   

   
   J Gen Virol

5. KALVELAGE L, Casteel M, Hartmann M, Harder TC, et al
   Environmental samples, a sensitive and practical alternative to individual bird sampling in the surveillance of H9N2 vaccinated turkey flocks.
   J Gen Virol. 2026;107:002279.
   

   >> Share

   
   

   
   J Infect

6. HARRIS R, Thirard R, McBrien C, Middleditch A, et al
   Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
   J Infect. 2026 Jun 4:106784. doi: 10.1016/j.jinf.2026.106784.
   

   >> Share

   
   

   
   J Infect Dis

7. LIU F, Gross FL, Li Z, House SL, et al
   Birth cohort effects in adults associated with influenza A(H1N1)pdm09 vaccine effectiveness.
   J Infect Dis. 2026 Jun 8:jiag294. doi: 10.1093.
   

   >> Share

   
   

   
   J Virol

8. JACKSON N, Bayoumi M, Nath H, Martinez-Sobrido L, et al
   Fluorescent protein-expressing Modified Vaccinia Ankara encoding T7 RNA polymerase.
   J Virol. 2026 Jun 12:e0075526. doi: 10.1128/jvi.00755.
   

   >> Share

   
   
9. ZHAI H, Gao Y, Wan N, Qu Y, et al
   A ubiquitinated E2-based mRNA vaccine confers complete protection against lethal challenge with classical swine fever virus.
   J Virol. 2026 Jun 12:e0026926. doi: 10.1128/jvi.00269.
   

   >> Share

   
   

   
   JAMA

10. SCHWEITZER K
    Inside the Push for a Fentanyl Vaccine.
    JAMA. 2026 Jun 12. doi: 10.1001/jama.2026.6392.
    

    >> Share

    
    
11. EDWARDS KM, Rathore MH
    Resurgence of Tetanus-Reasons Why the Vaccine Remains Instrumental.
    JAMA. 2026 Jun 8. doi: 10.1001/jama.2026.9347.
    

    >> Share

    
    

    
    Lancet

12. WHITEMAN M, Tundang R, Maybarduk P, Abdullah H, et al
    How CEPI can enhance global vaccine equity and transparency.
    Lancet. 2026 Jun 8:S0140-6736(26)01137-2. doi: 10.1016/S0140-6736(26)01137.
    

    >> Share

    
    
13. MEYER M, Kuzmin IV, Dews EA, Hyde MA, et al
    Single-dose mRNA vaccines against Andes hantavirus.
    Lancet. 2026 Jun 10:S0140-6736(26)01124-4. doi: 10.1016/S0140-6736(26)01124.
    

    >> Share

    
    

    
    Nat Med

14. NGONGO N, Fallah MP, Dereje N, Boum Y, et al
    Bundibugyo Ebola without vaccines or therapeutics: why public health fundamentals matter more than border closures.
    Nat Med. 2026 Jun 9. doi: 10.1038/s41591-026-04482.
    

    >> Share

    
    
15. ORTIZ JR, Kurup D, Kaufman AC, Ben Hamed S, et al
    Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial.
    Nat Med. 2026 Jun 9. doi: 10.1038/s41591-026-04429.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

16. KLINE M, Wyllie AL, McElwee K, Trammel J, et al
    Safety and Immunogenicity of 20-valent Pneumococcal Conjugate Vaccine According to Number and Timing of Primary Series Doses.
    Pediatr Infect Dis J. 2026 Jun 10. doi: 10.1097/INF.0000000000005291.
    

    >> Share

    
    

    
    Pediatrics

17. MORAN MC, Wikswo ME, Sahni LC, Boom JA, et al
    Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024.
    Pediatrics. 2026 Jun 8:e2025074382. doi: 10.1542/peds.2025-074382.
    

    >> Share

    
    
18. CATALDI JR, O'Leary ST
    Rotavirus Vaccines Are Safe and Effective: So Why Aren't All Children Protected?
    Pediatrics. 2026 Jun 8:e2026076103. doi: 10.1542/peds.2026-076103.
    

    >> Share

    
    

    
    PLoS One

19. BLOCK NGAYBE MG, Joseph KK, Hamzazai W, Deal CJ, et al
    Exploring HIV prevention preferences among key populations in Uganda: A qualitative study.
    PLoS One. 2026;21:e0349414.
    

    >> Share

    
    
20. MULLIN T, Plascak J, Tan A, Ford J, et al
    Trends in HPV vaccination initiation and completion among U.S. adolescents aged 13-17 years, 2021-2023: Findings from the National Immunization Survey-Teen.
    PLoS One. 2026;21:e0349299.
    

    >> Share

    
    
21. KOULIDIATI JL, Zoma RL, Nebie EI, Yameogo S, et al
    Cost analysis of a nationwide typhoid conjugate vaccine campaign in Burkina Faso.
    PLoS One. 2026;21:e0351148.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

22. 
    Correction for Salomon et al., The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination.
    Proc Natl Acad Sci U S A. 2026;123:e2617330123.
    

    >> Share

    
    

    
    Vaccine

23. ZAKI L, Ghaffarifar F, Sharifi Z, Horton J, et al
    Design and synthesis of RNA vaccines encoding SAG1 antigen of toxoplasma gondii and evaluation of immunogenicity and its protective efficacy against acute toxoplasmosis in BALB/c mice.
    Vaccine. 2026;88:128785.
    

    >> Share

    
    
24. DYRKTON N, Alam S, Shepherd S, Sana I, et al
    Anchoring convenience survey samples to a baseline census for vaccine coverage monitoring in global health.
    Vaccine. 2026;88:128820.
    

    >> Share

    
    
25. DONG B, Zheng M, Feng S, Jiang X, et al
    Autologous tumor lysate vaccines enhance anti-glioma immunity and prolong survival in a GL261 glioblastoma mouse model.
    Vaccine. 2026;88:128758.
    

    >> Share

    
    
26. DAGNEW AF, Schmidt AC, Cinar A, Garcia-Basteiro AL, et al
    The role of interferon-gamma release assays in tuberculosis vaccine trials: strengths, limitations, and implications beyond trial design.
    Vaccine. 2026;88:128822.
    

    >> Share

    
    
27. WANG S, Li Z, Zhang H, Sun Z, et al
    A recombinant goat pox virus expressing the Brucella OMP25 antigen conferring moderate protection against B. abortus in mice.
    Vaccine. 2026;85:128686.
    

    >> Share

    
    
28. JAVED N, Sabir M, Saqib MAN, Abbas S, et al
    Seroprevalence and predictors of measles antibody positivity among children aged 18-24 months in Pakistan: a national survey.
    Vaccine. 2026;85:128702.
    

    >> Share

    
    
29. DANCHIN M, Rak A, Vasiliadis S, Wang B, et al
    Maternal preferences for infant respiratory syncytial virus (RSV) preventives: an Australian discrete choice experiment.
    Vaccine. 2026;85:128710.
    

    >> Share

    
    
30. WANG R, Zhao Y, Yang J, Luo R, et al
    Systemic BCG administration induces transcription factor signature in CD4(+) T cells that cooperates with IL-12 signaling to drive antiviral Th1 differentiation.
    Vaccine. 2026;85:128720.
    

    >> Share

    
    
31. SUN Y, Keskinocak P, Kovacs SD, Steimle LN, et al
    Quantifying the benefits of improved operations for polio outbreak response: A model-based analysis.
    Vaccine. 2026;85:128689.
    

    >> Share

    
    
32. DE FIGUEIREDO A, Paterson P, Lin L, Mounier-Jack S, et al
    Changing socio-demographic determinants of seasonal influenza acceptance in England during the pandemic and a framework for predicting future acceptance.
    Vaccine. 2026;85:128629.
    

    >> Share

    
    
33. BIETZ A, Sandow P, Hartmann C, Steffan L, et al
    Real-time in-season monitoring of adult influenza vaccination coverage rates in Germany: results from a repeated cross-sectional online survey.
    Vaccine. 2026;88:128765.
    

    >> Share

    
    
34. WU X, Tao Y, Sun Y, Chen J, et al
    Cost-effectiveness of free influenza vaccination policy for Chinese older adults: a modeling analysis using real-world data.
    Vaccine. 2026;88:128782.
    

    >> Share

    
    
35. SATTLER N, Scheiblauer S, Hochreiter R, Kosulin K, et al
    Chikungunya virus-neutralizing antibody persistence four years after single-dose vaccination with VLA1553 (IXCHIQ(R)).
    Vaccine. 2026;88:128787.
    

    >> Share

    
    
36. AQUINO VH, Gomez ML
    Decoding yellow fever virus immunogenicity: Targeting highly effective epitopes of YFV for next-generation vaccine design.
    Vaccine. 2026;88:128779.
    

    >> Share

    
    
37. POURHASHEM Z, Siasi S, Nourani L, Yousefi H, et al
    Corrigendum to "Multi-antigen transmission-blocking malaria vaccine elicits Th1-biased antibody responses and SMFA-confirmed oocyst reduction in Anopheles stephensi" [Vaccine 84 (2026) 128683].
    Vaccine. 2026;88:128784.
    

    >> Share

    
    

    
    Virology

38. PLA H, Simon-Grife M, Cros S, Del Mar Fenech M, et al
    Vaccination with a PRRSV-1 modified live vaccine provides protection against a highly virulent PRRSV-1.1 Spanish strain challenge in piglets.
    Virology. 2026;623:110979.
    

    >> Share

    
    
39. UNO N, Ross TM
    Intramuscular administration of influenza hemagglutinin in one hind leg elicits similar protective immune responses as administration in two hind legs.
    Virology. 2026;621:110961.
    

    >> Share

    
    
40. ZHAO Y, Ma Z, Zhang Z, Lv J, et al
    Immune responses triggered by oral administration of recombinant Bacillus subtilis expressing the E2 protein of classical swine fever virus.
    Virology. 2026;621:110924.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share